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Background: Asthma is characterized by variable airflow obstruction and airway wall thick-
ening. Multidetector-row computed tomography (MDCT) is useful for the evaluation of airway
wall structural changes in asthma. The objective of the study is to assess the relationship
between airflow limitation and airway dimensions from the third to fifth generation bronchi
in asthma using MDCT.
Methods: Thirty-eight subjects with asthma underwent MDCT to measure the airway wall area
(WA) and luminal area (Ai), WA and Ai corrected by body surface area (BSA), up to the fifth
generation of the apical bronchus (B1) and the posterior basal bronchus (B10) of the right lung.
Results: WA/BSA, WA percentage (WA%) and Ai/BSA in the fifth generation were significantly
correlated with forced expiratory volume in 1 s (FEV1)% predicted. The correlation coefficients
betweenWA%andFEV1%predicted increasedwhen tracking the airways fromthe third to thefifth
generation (rZ0.25, p> 0.05; rZ0.40, p< 0.01; rZ0.63, p< 0.001 for B1; rZ0.23,
p> 0.05; rZ 0.47, p< 0.01; rZ 0.69, p< 0.001 for B10). At the generation 5, WA% was
greater and Ai/BSA was smaller in severe asthma than mild-to-moderate asthma.
Conclusion: These results suggest that airway flow limitation in asthma is closely related to the
more distal airways (third to fifth generation).
ª 2009 Elsevier Ltd. All rights reserved.t of Respiratory Medicine, Atami Hospital, International University of Health and Welfare, 13-1
3-0012, Japan. Tel.: þ81 557 81 9171; fax: þ81 557 83 6632.
jp (M. Hoshino).
9 Elsevier Ltd. All rights reserved.
Airway dimensions at MDCT in asthma 795Introduction
Asthma is characterized by variable airflow obstruction,
airway hyperreponsiveness, airway inflammation and
airway remodeling. In particular, airway remodeling
describes structural changes that in the asthmatic airway
collectively result in thickening of the airway wall and leads
to a component of fixed airway narrowing and airflow
obstruction. Histological studies show significant increases
in peripheral lung inflammation and remodeling.1,2 Trans-
bronchial biopsy and lung resection offer invaluable insight
into small airways disease in asthma, but are difficult to
obtain and/or invasive. Non-invasive evaluation of airways
by imaging with high resolution computed tomography
(HRCT) has been tried as an alternative procedure and was
found to evaluate airway remodeling, and the measure-
ment of airway wall thickness by HRCT has demonstrated
a correlation with disease severity and airflow obstruction
in asthma.3e6 Although a relationship between airway wall
thickness on HRCT and histological parameters does not
always appear in severe adult asthma or difficult child
asthma.7,8
On the other hand, analysis of airway dimensions in
small airways is beyond the spatial resolution limits of
CT.9,10 As the anatomy of the lung, most of the airways are
likely to run oblique rather than perpendicular to the plane
of the CT section. Therefore, for a two-dimensional CT
images, there is error in the method used to calculate the
cross-sectional wall area (WA) and airway luminal area (Ai).
The development of multidetector-row CT (MDCT) scans
makes it possible to depict airway dimensions precisely at
the fifth or sixth generation of bronchi using curved multi-
planar reconstruction (MPR) images.11,12 Recently, Hase-
gawa et al.13 demonstrated that airflow limitation in
chronic obstructive pulmonary disease (COPD) was closely
related to the dimensions of the distal airways (up to the
sixth generation) rather than proximal airways.
We hypothesized that airflow limitation of asthma is
more closely linked to airway dimensions of distal than
proximal airways. The purpose of the present study is to
examine the relationship between airway wall thickness
and lumen area from the third to the fifth generation of
bronchi using MDCT and airflow limitation in patients with
asthma.
Methods
Subjects
Forty-four subjects with asthma were recruited at St.
Marianna University Hospital between April 2007 and
October 2008. Asthma was defined according to the Amer-
ican Thoracic Society criteria. All subjects were non-
smokers and had a clear history of relevant symptoms,
documented reversible airway obstruction (>12% improve-
ment in forced expiratory volume in 1 s (FEV1) either
spontaneously or after administration of inhaled b2
agonists), and/or methacholine provocation concentration
causing a 20% fall in FEV1 (PC20)< 8 mg/ml. Emphysema
was ruled out by CT scanning and subjects had no disease
exacerbations for at least 1 month before the study. Sixpatients were excluded due to breathing motion artifacts.
The severity of asthma was classified according to the
Global Initiative for Asthma guidelines.14 Severity of asthma
was mild persistent in 14 patients, moderate persistent in
12, and severe persistent in 12. Blood samples were taken
for measurement of the serum eosinophil percentage, and
atopy was diagnosed on the presence of one or more
specific serum IgE antibodies against common inhalant
allergens. The study was approved by the ethics committee
of our institution, and informed consent to the study
protocol was obtained from all subjects.3-Dimensional analysis of airways
All subjects were scanned with a 64-MDCT (Aquilion-64,
Toshiba Medical, Tokyo, Japan). CT scans were performed
at full inspiration and breath-holds with subjects in the
supine position. All subjects were carefully instructed how
to perform breath-hold maneuvers before the study and
again prior to the scan. MDCT scan parameters were as
follows: collimation, 64 0.5 mm; 120 kV; 200 mA; 30 mGy;
rotation time, 0.5 s; pitch, 0.83. Images were reconstructed
using a standard reconstruction algorithm with a slice
thickness of 1 mm and a reconstruction interval of 0.5 mm.
Reconstruction data were transferred to the worksta-
tion, and reconstructed into three-dimensional bronchial
tree (Fig. 1A). On the workstation monitor, we could
identify the bronchial tree in the axial, sagittal, and
coronal MPR images with a window width of 1250 HU and
a window level of 650 HU. The selected bronchial
pathway was automatically converted to a curved MPR
image. The bronchial long-axis image appeared as a straight
pathway (Fig. 1B). We obtained short-axis images that were
exactly perpendicular to the long axis at any site. MDCT
scans were analyzed using automated, and newly devel-
oped software that was designed to segment the first to
fifth airway generation (Fig. 1C), and to allow the
measurement of WA and Ai obtained perpendicular to the
long axis of the airway (Ziosoft Inc., Tokyo, Japan). A
validation study was performed using phantoms to confirm
the acceptability of data using CT scans in our previous
study.15 From the central point of the lumen, rays fanning
out over 360 were examined to determine airway walls
along the rays using the full width at half-maximum prin-
ciple.16,17 After the process, we obtained values for Ai and
outer area of airway (Ao) at an interval of 0.5 mm along the
long axis. To measure airway dimensions, we selected two
bronchi, the apical bronchus (B1) and the posterior basal
bronchus (B10) of the right lung. We selected these bronchi
because there are relatively perpendicular to CT images
and have a less effect of transmitted cardiac motion arti-
facts. In this study, a segmental bronchus was defined as
the third generation bronchus at both B1 and B10. Analysis
was limited to the third through fifth generations and the
number of detected bronchi was low after fifth generation.
Mean values of Ai and Ao in each generation were calcu-
lated at three different points, the observer randomly
chose, that had completely depicted the outline of the
bronchial wall. We could measure three of the third, three
of fourth, and three of fifth generation in selected bronchi
on a per subject. WA was calculated as AoAi. The
Figure 1 The three-dimensional reconstruction of the bronchial tree (A) Coronal curved MPR rendering of MDCT scan with
posterior basal bronchus (B10) in the right lung (B) Short-axis image of selected bronchus perpendicular to the long axis is obtained
and the numbers of the bronchial generation are shown (C) MPR: multiplanar reconstruction; MDCT: multidetector row computed
tomography.
796 M. Hoshino et al.percentage wall area (WA%) was calculated as (WA/
Ao) 100. We then assessed the mean values of WA, WA%
and Ai for each generation from two bronchi (third gener-
ation, WA3, WA3%, Ai3; fourth generation, WA4, WA4%, Ai4;
fifth generation, WA5, WA5%, Ai5). As airway size may be
affected by body size, WA and Ai were normalized using
body surface area (WA/BSA, Ai/BSA). All airway dimensions
were measured by one observer (M.H.) in blinded fashion.
When the measurements were repeated, the observer was
blind to the previously obtained measurement data. Intra-
observer error was tested with an observer measuring WA%
and Ai for the same bronchus in 10 randomly selected
subjects twice at a 2 week interval and were assessed with
Bland-Altman analysis.18Pulmonary function tests
Pulmonary function tests and CT scans were performed on
the same day. Using a FUDAK-77 (Fukuda Electronic Inc.,
Tokyo, Japan), we measured FEV1, forced vital capacity
(FVC), and mid forced expiratory flow at 25e75 of FVC
(FEF25e75). FEV1 and FEF25e75 were expressed as percent-
ages of predicted values according to the prediction
equations of the Japanese Respiratory Society.19Statistical analysis
Data are expressed as mean SD. All statistical analyses
were performed using Stat View software (SAS Institute,
Cary, NC, USA). Comparison between two groups was
performed using unpaired t tests. Comparison of multiple
groups was performed using analysis of variance (ANOVA)
with Bonferroni correction. Stepwise multiple linear
regression identified variables that demonstrated an
independent significant association with outcome
measurements of CT parameters and pulmonary function
data. Linear regression analysis was used to evaluate the
relationship between the CT data and asthma duration.
A p value less than 0.05 was considered statistically
significant.
Results
Baseline characteristics
The clinical characteristics of the subjects are shown in
Table 1. Subjects with severe asthma were significantly
older and their disease duration was significantly longer
than mild asthma (p< 0.01, respectively). The serum
Table 1 Characteristics of subjects.
Mild asthma (nZ 14) Moderate asthma (nZ 12) Severe asthma (nZ 12)
Age (years) 46.1 (14.0) 44.5 (8.7) 61.9 (16.5)*y
Gender (M/F) 7/7 7/5 5/7
BSA (m2) 1.63 (0.13) 1.72 (018) 1.59 (0.20)
Disease duration (years) 7.5 (7.6) 13.1 (10.1) 19.2 (13.5)*
Atopy/non-atopy 11/3 10/2 6/6
Serum eosinophils (%) 4.3 (2.7) 5.1 (4.4) 2.6 (5.2)
PC20 (mg/ml) 2.45 (2.01) 1.96 (1.72) 1.22 (1.87)
FEV1 (% predicted) 93.6 (8.2) 73.2 (4.7)** 54.4 (5.5)**
yy
FEV1/FVC (%) 76.6 (4.8) 64.8 (6.3)** 53.9 (9.3)**
y
FEF25e75 (% predicted) 60.2 (13.9) 32.8 (9.9)** 16.8 (5.7)**
yy
Medication
Long acting b2 agonist 0 2 12
Leukotriene receptor antagonist 2 2 5
Theophylline 2 1 4
Inhaled corticosteroid 8 12 12
Oral corticosteroid 0 0 3
Data are presented as mean (SD). BSA: body surface area. PC20: provocation concentration of methacholine causing a 20% fall in FEV1.
FEV1: forced expiratory volume in 1 S; FVC: forced vital capacity; FEF25e75: mid forced expiratory flow at 25e75 of FVC. *p< 0.01;
**p< 0.001, vs Mild asthma. yp< 0.01; yyp< 0.001, vs Moderate asthma.
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groups. FEV1% predicted, FEV1/FVC, and FEF25e75% pre-
dicted in the subjects with severe and moderate asthma
were significantly lower than those of mild asthma
(p< 0.001, respectively).Table 2 Relationship between airway dimensions and pulmona
Measurements FEV1 (% predict
r-value
WA/BSA (mm2/m2)
B1 WA3/BSA 10.3 5.9 0.26
WA4/BSA 9.5 5.2 0.35*
WA5/BSA 7.9 4.2 0.46y
B10 WA3/BSA 10.9 5.8 0.33
WA4/BSA 10.0 5.5 0.43*
WA5/BSA 8.3 4.4 0.44y
WA (%)
B1 WA3 60.1 2.0 0.25
WA4 65.9 2.7 0.40y
WA5 72.9 4.3 0.63x
B10 WA3 58.9 2.4 0.23
WA4 63.9 2.3 0.47y
WA5 71.3 3.3 0.69x
Ai/BSA (mm2/m2)
B1 Ai3/BSA 8.3 2.3 0.23
Ai4/BSA 4.5 1.1 0.33*
Ai5/BSA 2.5 0.8 0.62x
B10 Ai3/BSA 8.8 1.7 0.25
Ai4/BSA 5.0 1.2 0.39*
Ai5/BSA 2.6 0.7 0.59x
Data are presented as mean SD. Correlation coefficients are shown (
luminal area; BSA: body surface area; FEV1: forced expiratory volume
flow at 25e75 of FVC.Measurements of airway parameters
The results of WA/BSA, WA%, Ai/BSA and correlations with
the pulmonary function are shown in Table 2. WA5% of B1
was significantly greater in subjects with severe asthmary function.
ed) FEV1/FVC (%) FEF25e75 (% predicted)
r-value r-value
0.32 0.18
0.41* 0.31
0.43* 0.36*
0.31 0.25
0.35* 0.29
0.43* 0.37*
0.25 0.27
0.44y 0.46y
0.62x 0.62x
0.24 0.27
0.49y 0.50y
0.64x 0.68x
0.26 0.25
0.28 0.29*
0.57x 0.56x
0.15 0.25
0.35* 0.41*
0.50x 0.55x
*p< 0.05; yp< 0.01; xp< 0.001). WA: airway wall area; Ai: airway
in 1 S; FVC: forced vital capacity; FEF25e75: mid forced expiratory
Table 3 Correlation coefficients between airway
dimensions and asthma duration.
Duration of asthma (years)
r-value
WA/BSA (mm2/m2)
WA3/BSA 0.05
WA4/BSA 0.09
WA5/BSA 0.06
WA (%)
WA3 0.17*
WA4 0.19*
WA5 0.25y
Ai/BSA (mm2/m2)
Ai3/BSA 0.22y
Ai4/BSA 0.19*
Ai5/BSA 0.27y
Correlation coefficients are shown (*p< 0.05; yp< 0.01).
WA: airway wall area; Ai: airway luminal area;
BSA: body surface area.
798 M. Hoshino et al.[75.0 (3.0)%] compared to subjects with mild [68.0 (1.2)%;
p< 0.001] and moderate asthma [70.6 (2.2)%; p< 0.01].
WA5% of B10 was significantly greater in subjects with
moderate [72.6 (3.5)%] and severe asthma [76.9 (4.1)%]
compared to subjects with mild asthma [68.9 (2.1)%;
p< 0.01. p< 0.001, respectively]. Ai5/BSA of both B1 and
B10 were significantly lower in subjects with moderate
[2.5 (0.4), 2.4 (0.8) mm2/m2] and severe asthma [2.0
(0.7), 1.9 (0.8) mm2/m2] than subjects with mild asthma
[3.1 (0.5), 3.3 (0.6) mm2/m2; p< 0.01, p< 0.001, respec-
tively]. However, there was no significant difference in
WA3% or Ai3/BSA among three groups (Fig. 2). There were
significant positive correlations between WA% and the
duration of asthma, and negative correlations between
Ai/BSA and the duration of asthma (Table 3). No signifi-
cant correlation was observed between airway dimensions
and age. There was a significant inverse correlation
between WA3% and PC20 in asthmatic subjects (rZ0.38,
p< 0.05).
Both WA4/BSA and WA5/BSA had significant negative
correlations with FEV1% predicted and FEV1/FVC. The WA%
of all generations except for the third generation had
significant negative correlations with pulmonary function
data. Ai4/BSA and Ai5/BSA had significant positive corre-
lations with FEV1% predicted and FEF25e75% predicted. For
both B1 and B10, the correlation coefficients tended to
increase as the airway size became smaller. Relationship50
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Figure 2 The distribution of WA (%) and Ai/BSA in the three asthm
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Figure 3 Relationship between (A) FEV1% predicted and WA%, and (B) Ai/BSA in the third generation and the fifth generation of
the posterior basal bronchus of the right lung. Significant correlations were found between FEV1% predicted and airway dimensions
in the fifth generation, but not in the third generation. Open circles, third generation; closed circles, fifth generation. WA: airway
wall area; Ai: airway luminal area; BSA: body surface area.
Airway dimensions at MDCT in asthma 799Reproducibility
Plots of average and difference between the two
measurements of WA% or Ai were obtained to assess
reproducibility, are shown in Fig. 4. For each plot, the mean
difference did not appreciably deviate from zero, and the
limits of agreement were small.Discussion
In the current study, we used an automated quantitative
software to measure the airway wall area and luminal area
using MDCT in subjects with asthma. We found that (1) WA/
BSA, WA%, and Ai/BSA in the fourth and fifth generation
were correlated with pulmonary function measurements;
(2) the correlation coefficients between CT parameters and
airflow limitation tended to increase as the airway size
decreased from the third to the fifth generation; (3) at the
generation 5, WA% was greater and Ai/BSA was smaller in
severe asthma than mild-to-moderate asthma. These
results suggest that airflow limitation in asthma may be
closely related to more distal than proximal airways.
Airway wall thickness contributes to the degree of airflow
obstruction in asthma.4e6 Furthermore, increased airwaywall
thickness measured by MDCT scan correlated with pathologic
measurement of lamina reticular thickness.20 Niimi et al.5
showed that airway wall thickness of the right apical
segmental bronchus inasthmatics hada significant correlation
with airflow obstruction. In contrast to their study, we found
a significant correlation between WA/BSA, WA% and FEV1%
predicted at generations 4 and 5. Furthermore, the associa-
tion between airway wall dimensions and airflow limitationB
-8
-6
-4
-2
0
2
4
6
50 55 60 65 70 75 80 85
+2SD
5.8
Mean
0.2
-2SD
-5.5
Mean WA (%)
)
%(
A
W
ni
ec
nereffi
D
A
Figure 4 Reproducibility for measurements of (A) percentage ai
difference between the two measurements is plotted against their
mean 2SD of the difference, respectively.werehigher by tracking the airways distally. Hasegawaet al.13
demonstrated by three-dimensional CT scans that the rela-
tionship between WA% and FEV1% predicted improved as
airway size decreased from the third to the sixth generations
of bronchi in COPD. These findings may reflect that the
remodeling in asthma and COPD has occurred dominant in the
more distal airways than large airways. Although airway
luminal area is not an essential index of airway disease by
itself, airway wall thickening, mucus hypersecretion, and
smooth muscle spasms contribute to airway narrowing. Our
results showed that significant correlation between Ai5/BSA
and pulmonary function measurements. Several groups
demonstrated that thedistributionofairway lumennarrowing
after inhaled methacholine shifted towards smaller airways,
and the airway wall significantly thickened in asthmatics.21,22
It has been reported that patients with more severe asthma
had a greater airway wall thickness than those with milder
asthma.3e6,20,23 At the fifth generation, airway wall thick-
ening asWA%was greater and airway narrowing as Ai/BSAwas
smaller in severe asthma compared with those of mild-to-
moderate asthma. The poor correlation between the CT
measurementsanddiseasedurationwas found in this study.Of
note, treatment with inhaled steroids decreases wall thick-
nessaneffect thatmightbereflected inourfindings.24,25 Ithas
also been suggested based on studies in children with difficult
asthma that remodeling can occur very early stage.8
Our study had some limitations. First, we assessed only
two bronchi, B1 and B10 of the right lung. The large airways
of normal subjects and asthmatics were found to narrow
heterogeneously except in small airways, and the degree of
heterogeneity was greater in asthmatics.21,26 However,
these studies had inherent technical limitations because
they analyzed two-dimensional images of the airways and-0.6
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rway wall area (WA) and (B) airway way luminal area (Ai). The
average. The solid and dotted lines represent the mean and the
800 M. Hoshino et al.thus could not identify which airway generation they were
actually measuring. The correlations of airflow limitation
and airway dimensions showed similar tendency in both B1
and B10. More recently, de Lange et al.27 reported that,
using hyperpolarized helium-3 magnetic resonance imaging,
methacholine induced regional airflow obstruction that
persisted or recurred in the same location. These findings
suggest that the obstructive process of airway remodeling
may not vary randomly in the lung. However, in patients with
asthma, variations of airway dimensions could occur in
different bronchi20 and further studies are required to
measure other parts of bronchi. Second, airway lumen varies
as a function of volume, and this effect may be more
prominent when airway compliance is abnormal.28 To keep
MDCTwithin standards of a routine imaging examination, we
did not use spirometric gating CT in this study. However,
subjects were trained to perform full inspiration and breath-
holds before the examination. Scanning was performed only
after these maneuvers were satisfactory achieved.
In conclusion, we have presented that airflow limitation
in asthma was correlated with the airway dimensions. The
correlation coefficients increased by tracking the airways
from the third to the fifth generation. Quantitative analysis
of airway dimensions using non-invasive MDCT identifies
distal airway changes and would be useful to evaluate the
efficacy of medications.
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